GLR-1-mediated glutamate-gated currents in Xenopus oocytes are dependent on Ce STG-1 and SOL-1. (A) Currents recorded in response to 1 mM glutamate application in Xenopus oocytes injected with combinations of SOL-1, GLR-1, and C. elegans STG-1, vertebrate stargazin, Apis STG1, or Dro STG1 cRNA. Oocytes were voltage-clamped at a holding potential of −70 mV. (B) Average peak glutamate-gated current amplitude in oocytes coinjected with GLR-1, SOL-1, and Ce STG-1 cRNA as a function of Ce STG-1 (black). Values are also indicated for vertebrate stargazin, Apis STG1, and Dro STG1 (gray). GLR-1 plus SOL-1 plus 0.1 ng of Ce STG-1, n = 21; plus 0.5 ng of Ce STG-1, n = 19; plus 2.5 ng of Ce STG-1, n = 16; plus 12.5 ng of Ce STG-1, n = 18; plus vert. stargazin, n = 9; plus Apis STG1, n = 6; plus Dro STG1, n = 5. In A and B, oocytes were injected with 8.3 ng of GLR-1 and 8.3 ng of SOL-1 cRNA. (C) Glutamate-gated currents in Xenopus oocytes injected with rat GluR1 alone or coinjected with Ce STG-1, Apis STG1, Dro STG1, or vertebrate stargazin cRNAs. (D) Average peak glutamate-gated current amplitude as a function of stargazin cRNA. GluR1, n = 12; plus vert. stargazin, n = 5; plus Ce STG-1, n = 12; plus Apis STG1, n = 5; plus Dro STG1, n = 4. In C and D, oocytes were injected with 0.1 ng of rat GluR1 and 8.3 ng of the indicated stargazin cRNA. (E) Western blot showing the relative surface expression of C. elegans HA::GLR-1 in the presence or absence of Ce STG-1. (F) Coimmunoprecipitation of HA::GLR-1 and STG-1::MYC from HEK 293 cells. IB, immunoblot.